CT-P63: Clinical Trials

2 trials of CT-P63, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Withdrawn 1

Follow CT-P63: new trials by email Literature Review of CT-P63 trials Research Report on CT-P63

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen
CT-P63 and CT-P66 / Placebo - COVID-19
Phase 3WithdrawnCelltrion2022-04-012022-07-25
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects
CT-P63, Placebo - SARS-CoV-2 Infection
Phase 1CompletedCelltrion242021-10-112022-08-11

Conditions studied

COVID-19 (2)

Sponsors

Celltrion (2)

Countries

Poland (1)

Top investigators

Monika Kiecana, Dr. (1)